pacman schreef op 19 januari 2021 09:46:
..Besides the
right management of cytokines profile and inflammatory
indices, patients with COVID-19 infection usually need to receive respiratory care conventionally. Additionally, if
needed, kidney replacement therapy should be considered
for a patient with AKI or impendent kidney failure due to
the cytokine storm. No specific vaccine or drug has been
developed for this disease so far, and further trials continue.
In addition to antiviral treatments including antiretroviral
agents like lopinavir and ritonavir, nucleoside analog
drugs like remdesivir have been shown to be effective as
an anti-rheumatoid drug
ff goed lezen en begrijpen... en toen kwam Ruconest ;-)